ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Rheumatology

Top Rheumatology Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOAN MERRILL MD

Rheumatology

474

$103K

50
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$218
Average prescription price

Avg: $153

JUDITH JAMES MD, PHD

Rheumatology

1,025

$178K

43
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

28%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$173
Average prescription price

Avg: $153

ELIZABETH TAYLOR-ALBERT M.D.

Rheumatology

1,168

$422K

129
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$362
Average prescription price

Avg: $153

KASHIF MUFTI M.D.

Rheumatology

1,171

$75.7K

170
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $153

AMY DEDEKE MD

Rheumatology

1,212

$190K

173
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$157
Average prescription price

Avg: $153

ROBERT HOWARD M.D.

Rheumatology

1,300

$149K

162
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $153

NANCY BROWN D.O.

Rheumatology

1,385

$327K

73
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$236
Average prescription price

Avg: $153

FAHED HAMADEH M.D.

Rheumatology

1,680

$247K

176
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$147
Average prescription price

Avg: $153

CHRISTINE CODDING MD

Rheumatology

1,773

$205K

237
128 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

54%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$115
Average prescription price

Avg: $153

CARRIE GILSTRAP D.O.

Rheumatology

2,044

$357K

195
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$175
Average prescription price

Avg: $153

MUHAMMAD GILLAN MD

Rheumatology

2,158

$439K

259
146 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

30%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$204
Average prescription price

Avg: $153

LINDA ZACHARIAS MD

Rheumatology

2,200

$308K

297
135 are 65+

34%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$140
Average prescription price

Avg: $153

ELLEN ZANETAKIS M.D.

Rheumatology

2,472

$484K

259
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$196
Average prescription price

Avg: $153

DEBBIE GLADD D.O.

Rheumatology

2,772

$551K

281
170 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$199
Average prescription price

Avg: $153

MARK HULSEY M.D.

Rheumatology

2,885

$538K

234
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$187
Average prescription price

Avg: $153

JAMES MCKAY D.O.

Rheumatology

3,034

$658K

335
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$217
Average prescription price

Avg: $153

ALAN MARTIN M.D.

Rheumatology

3,394

$652K

394
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$192
Average prescription price

Avg: $153

ISABEL VEGA M.D.

Rheumatology

3,838

$383K

441
282 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

33%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $153

ANA KUMAR M.D.

Rheumatology

4,341

$525K

353
158 are 65+

42%
patients receiving schedule two controlled substances

Avg: 8%

30%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$121
Average prescription price

Avg: $153

WILLIAM SCHNITZ MD

Rheumatology

4,439

$813K

454
307 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$183
Average prescription price

Avg: $153

MOHAMMAD KHAN MD

Rheumatology

4,447

$817K

532
353 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$184
Average prescription price

Avg: $153

ROBERT HYND MD

Rheumatology

4,528

$1.04M

616
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$229
Average prescription price

Avg: $153

ROBERT ARTHUR MD

Rheumatology

4,821

$477K

517
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $153

FREDERICK DELAFIELD M.D.

Rheumatology

5,274

$843K

413
320 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$160
Average prescription price

Avg: $153

WILLIAM SURBECK M.D.

Rheumatology

5,404

$668K

547
422 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$124
Average prescription price

Avg: $153

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank